These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15138998)

  • 21. Acute panmyelosis with myelofibrosis with EVI1 amplification.
    Grygalewicz B; Woroniecka R; Pastwińska A; Rygier J; Krawczyk P; Borg K; Makuch-Łasica H; Patkowska E; Pieńkowska-Grela B
    Cancer Genet; 2012 May; 205(5):255-60. PubMed ID: 22682625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia.
    Cui W; Sun J; Cotta CV; Medeiros LJ; Lin P
    Am J Clin Pathol; 2011 Aug; 136(2):282-8. PubMed ID: 21757602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements.
    Lindvall C; Nordenskjöld M; Porwit A; Björkholm M; Blennow E
    Haematologica; 2001 Nov; 86(11):1158-64. PubMed ID: 11694401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
    Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G
    Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia.
    Tosi S; Hughes J; Scherer SW; Nakabayashi K; Harbott J; Haas OA; Cazzaniga G; Biondi A; Kempski H; Kearney L
    Genes Chromosomes Cancer; 2003 Oct; 38(2):191-200. PubMed ID: 12939747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome.
    Li S; Yin CC; Medeiros LJ; Bueso-Ramos C; Lu G; Lin P
    Am J Clin Pathol; 2012 Jul; 138(1):146-52. PubMed ID: 22706870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rare t(1;11)(q23;p15) in therapy-related myelodysplastic syndrome evolving into acute myelomonocytic leukemia: a case report and review of the literature.
    Zhang L; Alsabeh R; Mecucci C; La Starza R; Gorello P; Lee S; Lill M; Schreck R
    Cancer Genet Cytogenet; 2007 Oct; 178(1):42-8. PubMed ID: 17889707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
    Lin P; Medeiros LJ; Yin CC; Abruzzo LV
    Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.
    Ottema S; Mulet-Lazaro R; Beverloo HB; Erpelinck C; van Herk S; van der Helm R; Havermans M; Grob T; Valk PJM; Bindels E; Haferlach T; Haferlach C; Smeenk L; Delwel R
    Blood; 2020 Jul; 136(2):224-234. PubMed ID: 32219447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia.
    Wieser R; Volz A; Vinatzer U; Gardiner K; Jäger U; Mitterbauer M; Ziegler A; Fonatsch C
    Biochem Biophys Res Commun; 2000 Jun; 273(1):239-45. PubMed ID: 10873593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia.
    Trubia M; Albano F; Cavazzini F; Cambrin GR; Quarta G; Fabbiano F; Ciambelli F; Magro D; Hernandezo JM; Mancini M; Diverio D; Pelicci PG; Coco FL; Mecucci C; Specchia G; Rocchi M; Liso V; Castoldi G; Cuneo A
    Leukemia; 2006 Jan; 20(1):48-54. PubMed ID: 16619048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features.
    Stevens-Kroef M; Poppe B; van Zelderen-Bhola S; van den Berg E; van der Blij-Philipsen M; Geurts van Kessel A; Slater R; Hamers G; Michaux L; Speleman F; Hagemeijer A
    Leukemia; 2004 Jun; 18(6):1108-14. PubMed ID: 15085164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH study.
    Andersen MK; Christiansen DH; Pedersen-Bjergaard J
    Genes Chromosomes Cancer; 2005 Apr; 42(4):358-71. PubMed ID: 15645489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.
    Beyer V; Mühlematter D; Parlier V; Cabrol C; Bougeon-Mamin S; Solenthaler M; Tobler A; Pugin P; Gregor M; Hitz F; Hess U; Chapuis B; Laurencet F; Schanz U; Schmidt PM; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2005 Jul; 160(2):97-119. PubMed ID: 15993266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.
    Baldazzi C; Luatti S; Zuffa E; Papayannidis C; Ottaviani E; Marzocchi G; Ameli G; Bardi MA; Bonaldi L; Paolini R; Gurrieri C; Rigolin GM; Cuneo A; Martinelli G; Cavo M; Testoni N
    Genes Chromosomes Cancer; 2016 Apr; 55(4):375-88. PubMed ID: 26815134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.